#ResearchRoundUp Marjaana Koponen was published in Osteoporosis International. Her study with researchers from @thisisFINLAND looked at long term thiazide use and the risk of fractures in people with #AlzheimersDisease https://t.co/GEH7KAd8pX
This Osteoporosis International study extends the previous knowledge of reduced fracture risk of thiazides to persons with Alzheimer’s disease, a population with significantly increased background risk of fractures. Read more: https://t.co/zk1qCXFoHO https
Thiazides may protect against fracture in Alzheimer's patients, via Osteoporosis International https://t.co/TGKtC9geWE
Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study. - PubMed - NCBI https://t.co/O9UF5YwziC
RT @37phoenix: アルツハイマー病患者においてサイアザイドの使用は低エネルギー骨折のリスク減少と関連する。Osteoporos Int. PMID: 30993395 https://t.co/nqhbfVm9iA
アルツハイマー病患者においてサイアザイドの使用は低エネルギー骨折のリスク減少と関連する。Osteoporos Int. PMID: 30993395 https://t.co/nqhbfVm9iA
Thiazide use > 3 yrs associated with a reduced risk of low energy fracture (0.77; 0.71–0.83) and hip fracture (0.68; 0.60–0.78) among community dwellers with Alzheimer’s disease in large Finnish cohort. Taipale H et al. Osteoporos Int 16 Apr 2019 http